TELA Bio (TELA) Income from Continuing Operations (2018 - 2026)
TELA Bio (TELA) recorded quarterly Income from Continuing Operations of 12273000.0 in Q1 2026, down 29.83% quarter-over-quarter from 9453000.0 in Q4 2025, and down 8.96% on a YoY basis from 13480553.1 in Q1 2025.
TELA Bio (TELA) Income from Continuing Operations (2018 - 2026) Analysis & Trends
TELA Bio's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 12273000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 8.96% year-over-year to 12273000.0; the TTM figure through Mar 2026 stood at 40252000.0 (down 706.98% YoY), while the FY2025 annual figure was 39243000.0, down 5270.36% from the prior year.
- Income from Continuing Operations was 12273000.0 for Q1 2026 at TELA Bio, down from 9453000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 29248000.0 in Q4 2024 to a low of 13623000.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 8426882.35 across 5 years, with a median of 10755000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 314.7% in 2024, then tumbled 132.32% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 10613000.0 in 2022, then fell by 28.36% to 13623000.0 in 2023, then jumped by 314.7% to 29248000.0 in 2024, then sank by 132.32% to 9453000.0 in 2025, then retreated by 29.83% to 12273000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 12273000.0 (Q1 2026), 9453000.0 (Q4 2025), and 8603000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | TELA Bio | 48.23 Mn | 8.69 Mn | 12.52 Mn | -12.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.27 Mn |
| Dec 31, 2025 | -9.45 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | -13.62 Mn |
| Sep 30, 2023 | -11.52 Mn |
| Jun 30, 2023 | -11.66 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -10.61 Mn |
| Sep 30, 2022 | -10.52 Mn |
| Jun 30, 2022 | -11.17 Mn |
| Mar 31, 2022 | -10.76 Mn |
| Dec 31, 2021 | -8.58 Mn |
| Sep 30, 2021 | -8.14 Mn |
| Jun 30, 2021 | -8.18 Mn |